ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2025
Prevalence of Helicobacter pylori cagA virulence factor and validation of serological tests in a population from Northeastern Brazil.
Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Helicobacter pylori is an infectious agent linked to significant gastric pathologies, which makes it a public health concern. The enzyme-linked immunosorbent assay (ELISA) is widely used for epidemiological studies and for investigating virulence factors like the cagA gene. Due to the varying antigenic profiles of bacterial strains across different populations, the local validation of serological tests is essential. This study aimed to evaluate the performance of two commercial serological tests - the MyBiosource HP-CagA-IgG ELISA kit and the Sunlong Human IgG (CagA-IgG) ELISA kit - in detecting the cagA virulence factor and to assess its prevalence in bacterial isolates from a population in the southwest region of Bahia. A total of 88 individuals were enrolled, and 34 tested positive for the cagA factor via real-time PCR. After establishing customized cutoff points, the MyBiosource kit demonstrated a sensitivity of 55.88%, specificity of 50%, and accuracy of 52.22%, while the Sunlong kit showed a sensitivity of 70.59%, specificity of 60%, and accuracy of 64.29%. Despite these results, neither test met satisfactory performance standards, with sensitivity below 75% and specificity ranging from 50 to 60%. The overall prevalence of H. pylori infection was 56.8%, with a cagA prevalence of 68% among positive cases. Further investigations using additional commercial tests are recommended to enhance diagnostic outcomes for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.